Pre-polycystic ovary syndrome and polymenorrhoea as new facets of polycystic ovary syndrome (PCOS): Evidences from a single centre data set

被引:4
|
作者
Ganie, Mohd Ashraf [1 ,2 ]
Rashid, Aafia [2 ]
Baba, Mohammad Salem [1 ]
Zargar, Mohd Afzal [3 ]
Wani, Imtiyaz Ahmad [2 ]
Nisar, Sobia [4 ]
Wani, Ishfaq Ahmad [2 ]
Douhath, Syed [2 ]
Sriwastawa, Mukesh [5 ]
Geer, Mohd Ishaq [6 ]
Asrar, Mir Mohd [2 ]
Kutum, Rintu [7 ,8 ]
Hassan, Saqib [9 ]
Khan, Shahid [10 ]
Rafi, Wajid [11 ]
Bhat, Dil Afroz [12 ]
Showkat, Wasia [2 ]
Sahar, Tajali [2 ]
Choh, Naseer Ahmad [13 ]
Khurshid, Rabia [14 ]
Mudassar, Syed [12 ]
Shah, Zafar Amin [15 ]
Shabir, Iram
Sofi, Sanjeed Ahmad [13 ]
Gupta, Nandita [11 ]
Hafeez, Imran [16 ,17 ]
Sreenivas, Vishnubatla [18 ]
机构
[1] Sheri Kashmir Inst Med Sci, Dept Endocrinol, Srinagar, India
[2] Sheri Kashmir Inst Med Sci, Dept Clin Res, Srinagar, India
[3] Cent Univ Kashmir, Dept Life Sci, Ganderbal, India
[4] Govt Med Coll, Dept Med, Srinagar, India
[5] Univ Louisville, Dept Microbiol & Immunol, Louisville, KY USA
[6] Univ Kashmir, Dept Pharmacol, Srinagar, India
[7] Ashoka Univ, Dept Comp Sci, Sonepath, India
[8] Ashoka Univ, Trivedi Sch Biosci, Dept Comp Sci, Sonepath, India
[9] Deemed Univ, Sathyabama Inst Sci & Technol, Sch Bio & Chem Engn, Dept Biotechnol, Chennai, India
[10] AIIMS New Delhi, Dept Lab Med, New Delhi, India
[11] All India Inst Med Sci, Dept Endocrinol, New Delhi, India
[12] Sheri Kashmir Inst Med Sci, Dept Clin Biochem, Srinagar, India
[13] Sheri Kashmir Inst Med Sci, Dept Radiodiag & Imaging, Srinagar, India
[14] Sheri Kashmir Inst Med Sci, Dept Obstet & Gynecol, Srinagar, India
[15] Sheri Kashmir Inst Med Sci, Dept Immunol & Mol Med, Srinagar, India
[16] Iowa State Univ, Dept Biochem, Ames, IA USA
[17] Sheri Kashmir Inst Med Sci, Dept Cardiol, Srinagar, India
[18] All India Inst Med Sci, Dept Biostat, New Delhi, India
关键词
India; metabolism; oligomenorrhoea; PCOS; phenotype; polymenorrhoea; Pre-PCOS; INSULIN-RESISTANCE; METABOLIC SYNDROME; MENSTRUAL CYCLES; WOMEN; MORPHOLOGY; CRITERIA; SPIRONOLACTONE; ASSOCIATION; ADOLESCENTS; POPULATION;
D O I
10.1111/cen.14964
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectivePolycystic ovary syndrome (PCOS) is a complex disorder with diverse metabolic implications. Diagnosis typically relies on oligo-amenorrhoea (OA), hyperandrogenism (HA), and polycystic ovarian morphology (PCOM). However, the role of polymenorrhoea in PCOS remains understudied. Additionally, limited information exists regarding metabolic disturbances in women with partial PCOS phenotypes that do not meet diagnostic criteria. This extensive database aims to provide substantial evidence on the metabolic implications of polymenorrhoea and partial PCOS phenotypes.DesignProspective observational study.Patients and MeasurementsIn this single-centre study, 6463 women with PCOS-like characteristics and 3142 age-matched healthy women were included. The study compared clinical (anthropometry, modified Ferriman Gallwey [mFG] score), hormonal (serum testosterone), and metabolic (plasma glucose, serum lipids, insulin) characteristics between women diagnosed with PCOS, those with partial PCOS phenotypes, and the healthy control groupResultsIn all, 5174 women met Rotterdam criteria for PCOS diagnosis, while 737 were classified as Pre-PCOS, including HA (n = 538), OA (n = 121), or PCOM (n = 78). Common clinical features included oligomenorrhoea (75.5%), hirsutism (82.9%), obesity (27.2%), hypertension (1.6%), metabolic syndrome (19.6%), and diabetes mellitus (5.6%). Women diagnosed with PCOS, HA only, and OA only exhibited higher average body mass index, plasma glucose levels (both fasting and 2 h after the oral glucose tolerance test), and lipid fractions in comparison to those with PCOM and the healthy controls. However, indices of insulin resistance were similar among women with PCOS, HA, PCOM, and OA, albeit higher than in the healthy controls. The polymenorrhoea subgroup (5.9%) had lower BMI and serum testosterone, but similar mFG score, plasma glucose, insulin, and lipid levels as the oligomenorrhoea subgroup.ConclusionThe metabolic disturbances observed in Pre-PCOS women highlight the need to reassess diagnostic criteria. Including the polymenorrhoea subcategory in PCOS criteria is recommended due to similar metabolic dysfunctions as the oligomenorrhoea group.
引用
收藏
页码:566 / 578
页数:13
相关论文
共 50 条
  • [21] Role of obesity in polycystic ovary syndrome (PCOS)
    Lanzone, A
    Fulghesu, AM
    Guido, M
    Cucinelli, F
    Villa, P
    Ciampelli, M
    Pavone, V
    Murgia, F
    Apa, R
    Cento, R
    Proto, C
    Caruso, A
    Mancuso, S
    OVARY: REGULATION, DYSFUNCTION AND TREATMENT, 1996, 1106 : 229 - 235
  • [22] Prolactin secretion in polycystic ovary syndrome (PCOS)
    Szosland, Konrad
    Pawlowicz, Pawel
    Lewinski, Andrzej
    NEUROENDOCRINOLOGY LETTERS, 2015, 36 (01) : 53 - 58
  • [23] Application of a new ultrasound criterion for the diagnosis of polycystic ovary syndrome
    Gimenez-Peralta, Ivan
    Lilue, Mariela
    Mendoza, Nicolas
    Tesarik, Jan
    Mazheika, Marina
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [24] Polycystic Ovary Syndrome (PCOS): Symptoms, Causes, and Treatment
    Bai, Hai
    Ding, Huanhuan
    Wang, Mingming
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2024, 51 (05)
  • [25] Polycystic ovary syndrome (PCOS) and adolescence: How can we manage it?
    Capozzi, A.
    Scambia, G.
    Lello, S.
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2020, 250 : 235 - 240
  • [26] Shift in the Relation of Inflammatory Markers in a Collective with Polycystic Ovary Syndrome (PCOS)
    Knebel, B.
    Lehr, S.
    Janssen, O. E.
    Hahn, S.
    Nitzgen, U.
    Jacob, S.
    Haas, J.
    Mueller-Wieland, D.
    Kotzka, J.
    DIABETOLOGIE UND STOFFWECHSEL, 2011, 6 (01) : 48 - 54
  • [27] Biological insulin resistance in Congolese woman with polycystic ovary syndrome (PCOS)
    Amisi, C.
    Mputu, L.
    Mboloko, E.
    Bieleli, E.
    Pozzili, P.
    GYNECOLOGIE OBSTETRIQUE & FERTILITE, 2013, 41 (12): : 707 - 710
  • [28] Recommendations for epidemiologic and phenotypic research in polycystic ovary syndrome: an androgen excess and PCOS society resource
    Azziz, Ricardo
    Kintziger, Kristina
    Li, Rong
    Laven, Joop
    Morin-Papunen, Laure
    Merkin, Sharon Stein
    Teede, Helena
    Yildiz, Bulent O.
    HUMAN REPRODUCTION, 2019, 34 (11) : 2254 - 2265
  • [29] Role of Metformin in Polycystic Ovary Syndrome (PCOS)-Related Infertility
    Attia, Ghalia M.
    Almouteri, May M.
    Alnakhli, Fatimah T.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (08)
  • [30] Polycystic ovary syndrome (PCOS) and endocrine disrupting chemicals (EDCs)
    Eleni Palioura
    Evanthia Diamanti-Kandarakis
    Reviews in Endocrine and Metabolic Disorders, 2015, 16 : 365 - 371